11. Development of a Strategy for Analysis of Genotoxic Impurities

  1. Andrew Teasdale
  1. Andrew Baker

Published Online: 3 JAN 2011

DOI: 10.1002/9780470929377.ch11

Genotoxic Impurities

Genotoxic Impurities

How to Cite

Baker, A. (2011) Development of a Strategy for Analysis of Genotoxic Impurities, in Genotoxic Impurities (ed A. Teasdale), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470929377.ch11

Editor Information

  1. AstraZeneca, Leicester, United Kingdom

Author Information

  1. AstraZeneca, Leicester, United Kingdom

Publication History

  1. Published Online: 3 JAN 2011
  2. Published Print: 14 FEB 2011

ISBN Information

Print ISBN: 9780470499191

Online ISBN: 9780470929377

SEARCH

Keywords:

  • development of a strategy - for analysis of genotoxic impurities;
  • AstraZeneca strategy, recommended - making use of existing knowledge or practical experience, relevant to task in hand;
  • sample preparation, singularly most important - undervalued aspects of GI analysis

Summary

This chapter contains sections titled:

  • Introduction

  • Access to Knowledge and Information

  • Technical Understanding

  • Business Requirements

  • Method Validation

  • Summary

  • Acknowledgments

  • References